How to establish a successful ex vivo lung perfusion program by Makdisi, George & Wozniak, Thomas C.
Page 1 of 4
© Annals of Translational Medicine. All rights reserved. Ann Transl Med 2017;5(Suppl 1):S12atm.amegroups.com
Editorial
How to establish a successful ex vivo lung perfusion program
George Makdisi1,2, Thomas C. Wozniak2
1Division of Cardiothoracic Surgery, Tampa General Hospital, University of South Florida, Tampa, FL, USA; 2Division of Cardiothoracic Surgery, 
Indiana University Health, Indianapolis, IN, USA
Correspondence to: George Makdisi, MD. Indiana University Health, CV Surgery- Transplant 1801 N. Senate Blvd., MCP2, Suite 2000, Indianapolis, 
IN 46202, USA. Email: gmakdisi@hotmail.com.
Submitted Feb 22, 2017. Accepted for publication Feb 27, 2017.
doi: 10.21037/atm.2017.03.11
View this article at: http://dx.doi.org/10.21037/atm.2017.03.11
Introduction
Lung transplant is the ultimate solution for patients with 
end stage respiratory failure. The number of patients 
awaiting transplant continues to rise, and waitlist 
mortality is a growing concern due to the donor lung 
shortage (1-3). Donor lungs are subjected to several 
injurious mechanisms during the brain death/organ 
donation process (such as ventilator-acquired pneumonia, 
neurogen i c  and  hydros t a t i c  pu lmonary  edema , 
barotrauma, etc.) (2). Because of this, the majority of 
offered lungs are not used; only 15–20% of offered lungs 
are currently utilized (4-6). Expansion of the donor pool 
has been accomplished utilizing extended criteria donors, 
donation after cardiac death (DCD), and aggressive use 
of ECMO post-transplantation for marginal lungs (6-9). 
With the use of ex vivo lung perfusion (EVLP), even 
“more marginal” lungs can be assessed in an ex vivo 
setting prior to transplantation. By doing so, lungs that 
are deemed acceptable for implantation will expand 
the donor pool while those lungs that are deemed 
unacceptable and discarded and will help preserve or 
potentially improve outcomes. The EVLP is used in high-
risk donor lungs which are defined as those meeting any 
one of the following criteria: (I) best ratio of the partial 
pressure of arterial oxygen (PaO2) to fraction of inspired 
oxygen (FIO2) of less than 300 mmHg; (II) pulmonary 
edema, defined as bi lateral  interstit ial  infi ltrates 
without evidence of infection, detected on the last 
chest radiograph by the lung-transplantation physician 
assessing the donor; (III) poor lung deflation or inflation 
during direct intraoperative visual examination at the 
donor site; (IV) blood transfusions exceeding 10 units; 
(V) DCD (2,10).
Donor lungs with established pneumonia, severe 
mechanical lung injury (i.e., contusions in more than one 
lobe), or gross gastric aspiration were excluded (10).
EVLP has emerged as a valuable potential alternative 
to address this issue by utilizing a preservation technique 
that allows for more accurate lung assessment and 
possible improvement of lung function (2). The concept of 
EVLP is not only to evaluate lungs before transplantation, 
but also to recondition lungs of inferior quality outside 
the cadaver and to extend the total cold ischemic time by 
intermittent warm reperfusion (11). Early outcomes have 
been reported in recipients who underwent transplantation 
after EVLP to those with conventionally selected and 
transplanted lungs (11-14).
Discussion
Here we discuss how to establish a successful EVLP program 
by in seven steps (15), we carefully considered various 
factors which are important in implantation this technology 
step by step focusing on liaison, logistics, and organization,a 
number of recommendations have particular relevance to 
the American situation, but it could be used as a road map 
or a guidance for different national health care systems too.
Step 1: identify the need for an EVLP program
Being realistic is a key to success. Hospital administration 
should ensure that they have the resources, but you need 
to be sure that the program will succeed. You need to 
evaluate the potential number of EVLP cases you might be 
able to perform, as an EVLP program might not be a cost 
effective. You should also be willing to accept marginal 
lungs and be comfortable with the possibility that the 
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lungs might not be suitable for transplant after mobilizing 
resources and time spent by your team. The preferable 
scenario is one in which a program has sufficient volume, 
and a robust waiting list.
Step 2: identify the physician leadership team
This includes Physician champions in the form of a qualified 
lung transplant surgeon and lung transplant pulmonologist; 
both will need to be willing to sacrifice sufficient time and 
efforts to proceed with this labor-intensive endeavor. Both 
need to have enough knowledge and master their subject 
as they will be the reference for all team members and the 
primary decision makers. Theses project champions will 
continuously oversee the program, periodically reassess 
and manage patient selections, and ensure high quality 
outcomes. They also need to critically analyze policies, 
training, annual competencies and recommend restructuring 
when indicated.
Step 3: receive support from the hospital leadership
In order to start an EVLP program, it is essential to 
have full administration support in order to secure 
start-up capital investment. The administration should 
understand the purpose of the program and be willing to 
invest continuing support to the project as the return on 
investment may not occur immediately. You will need to 
perform a cost analysis and the impact that EVLP would 
have on transplant program. The analysis should include 
the cost of purchasing disposable EVLP materials, staff 
salary, estimated call cost, and continuous training and 
education as well as scheduled maintenance. Key points 
in persuading your administration to commit the start-up 
capital would include the potential for more transplants 
and associated down-stream revenue, marketability, and 
increased visibility of the program to patients and referring 
physicians. These are some tips for engaging leaders in 
your project (16,17).
(I)	Understand your  leader ’s  s ty le :  know the 
personality of the person to whom you are trying to 
“sell” the idea or program to is critical to success. 
You need to find out what convinces the leader; 
numbers or stories;
(II)	Find the best pathway to the administration: try to 
build a cross-disciplinary team (guiding coalition) 
of other department leaders, hospital frontline 
staff, patients and families who support the work. 
Within the group some people who have credibility 
with others, these people are volunteer to help (17). 
Having these diverse voices of support will build 
leverage for getting leadership buy-in;
(III)	Be sure to establish a clear, ambitious vision that 
can inspire: talk about both the short-term and 
long-term implications of the initiative. Use 
evidence and experts to make your case, providing 
excellence can only be done by using evidence-
based practices. Leaders want to know you have 
done your homework before committing resources 
to a new project, in general initial impressions are 
very strong and they can be hard to counteract;
(IV)	Align with external priorities: leadership is more 
likely to support a project that aligns with the 
future of their field. Appeal to your leaders by 
aligning your initiative with national priorities, 
especially those that are cutting edge; 
(V)	Communicate: by using all channels as (meeting, 
emails, one on one conversations). Getting 
administration buy-in is only half the battle. They 
still needed the go-ahead from leadership to fund 
the project once leaders are onboard with a project, 
it’s important to frequently share information to help 
transition them from supportive to engaged (18).
Step 4: build your own circuit to establish proficiency
An EVLP circuit can be built utilizing components available 
from the perfusion and respiratory departments of your 
institution. The basic components of an EVLP circuit 
include a ventilator, endotracheal tube, perfusion solution, 
tubing pack, reservoir, oxygenator, air filter, and pump. 
An O2 sensor is helpful but not mandatory. In addition, a 
tank of “de-oxygenating gas” is necessary to simulate O2 
consumption by the circuit. Cannulas for the pulmonary 
artery and left atrial cuff are commercially available as are 
many of the above-mentioned components (Figure 1).
Step 5: identify your clinical team
Staffing of the circuit can take many forms. These 
employees will become staff level champions. These 
should include individuals with knowledge of perfusion, 
ventilator management, and arterial blood gas (ABG) 
interpretation. In addition to a physician, this can include 
perfusionists, respiratory therapists, extracorporeal 
membrane oxygenation (ECMO) clinicians, transplant 
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OR staff, and research coordinator. Engaging diverse staff 
throughout the planning, design, and implementation of 
program improvement strategies is critical to facilitating 
successful and lasting change.
At our institution, an extracorporeal membrane 
oxygenation respiratory therapist (clinician) (RT-ECMO) 
is the sole staffing individual for an EVLP. This model was 
chosen because these individuals have an understanding of 
perfusion, ventilator management, and ABG interpretation. 
We have identified two people from day shift and two 
people from night shift for this position as one of them are 
in-house greater than 90% of the year. They are listed on 
our transplant call schedule and readily available on short 
notice for any clinical perfusion. They are supervised during 
an EVLP by a lung transplant physician.
Step 6: establish your staffing and training model
At present, EVLP is an infrequent event when compared 
to lung transplant. Once these components and individuals 
are in place, it is helpful to utilize a structured competency 
model of mock loops and non-human lungs to become 
familiar with the technique of EVLP. If non-human 
lungs are used, it is imperative to receive institutional 
review board (IRB) and Institutional Animal Care and 
Use Committee (IACUC) approval from your institution. 
Again, this will require institutional support in the form of 
compensation for educational time of your staff. You should 
also anticipate and address the staff resistance and culture 
change, continuous education is a key point for success. Off 
note whenever you start a new process, you always find that 
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Figure 1 EVLP circuit. EVLP, ex vivo lung perfusion.
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the time you’ve allocated for education is not enough.
Step 7: purchase your machine
Select the more convenient type of EVLP to your 
institution considering the above will be helpful in 
achieving a smooth transition to clinical application in a 
lung transplant program.
Summary
EVLP is becoming more prevalent and accepted technology 
in the armamentarium of lung transplantation. The key to 
any successful EVLP program is having a coordinated team 
of professionals who dedicate a significant portion of their 
time to the program. In order to start an EVLP program, it 
is essential that sufficient institutional support and staffing 
be available. Once established, it is imperative that ongoing 
training and proficiency methods are in place in order to 
assure optimal results.
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